Skip to content

Comparison of Different Tourniquet Release Times in Bunion Surgery

Evaluation of Post-operative Swelling and Functional Outcomes in Relation to Pneumatic Tourniquet Use Pattern in Bunion Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03616847
Enrollment
80
Registered
2018-08-06
Start date
2018-08-23
Completion date
2021-11-25
Last updated
2019-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Rigidus, Hallux Valgus

Keywords

Randomised controlled trial, Hallux valgus correction, Hallux rigidus correction, Tourniquet, Foot volume

Brief summary

Patients listed for hallux valgus/hallux rigidus correction surgery will be randomised to one of two treatment groups. Group 1 (standard care) will have the calf tourniquet released after wound closure. Group 2 will have the tourniquet removed five minutes before wound closure. Participants will have the volume of their operated foot measured pre-operatively and post-operatively at six weeks and three months.

Detailed description

Pneumatic tourniquets provide the benefits of better visualisation and decreased blood loss, but can also cause metabolic changes due to ischemia and compressive damage due to pressure. Surveys of foot and ankle surgeons demonstrates prevalent use of tourniquets in their clinical practice, with various patterns of use differing amongst the surgeons. Bunion surgery is one of the most common surgical procedures in foot surgery. It involves correcting the hallux valgus deformity through a combination of various osteotomy, fusion, or soft tissue procedures. Swelling after any surgery is common, but particularly so after foot surgery as gravity causes fluid to collect in the foot. With regards to recovery after surgery, patients are advised to expect to be off work for between 6-8 weeks for a sedentary occupation, and between 12-14 weeks for heavy work. Although patients have low pain levels, the foot remains swollen for an average of 3-6 months after surgery. It is usually the swelling that prevents patients from getting in to normal footwear to be able to return to work sooner. Bunion surgery is usually performed under a calf-tourniquet to create a bloodless surgical field and ensure less surgical bleeding, thereby reducing surgical time. However, use of tourniquets can lead to more swelling, increased post-operative pain and challenges in rehabilitation - all of which may affect recovery after bunion surgery. Prolonged duration of tourniquet use has been shown to cause post-operative wound healing complications, potentially attributable to local inflammation and tissue hypoxia. It is known from the studies for knee replacement surgery that tourniquet use can lead to decreased range of motion after surgery in early stage. This study will be a randomised controlled trial with two study groups. The control group will have surgery with the tourniquet remaining in situ until the wound is closed. The intervention group will have the tourniquet released after surgery, but closure will be delayed by five minutes.

Interventions

OTHERStandard care

Hallux valgus/hallux rigidus surgery with the calf tourniquet remaining in situ until the wound is closed.

OTHERTourniquet release

Hallux valgus/hallux rigidus surgery with the calf tourniquet released five minutes before the wound is closed.

Sponsors

Golden Jubilee National Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Those collecting and analysis the data will be masked to the treatment groups. It is not possible to mask the participant or the care provider in this study

Intervention model description

Two randomised study groups with one having standard care and the other the intervention.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients having hallux valgus or hallux rigidus * Able to give informed consent * Able to return for follow-up

Exclusion criteria

* Patients with symptomatic peripheral vascular disease * Patients with known peripheral oedema from any cause * Patients who will also require lesser toe correction as part of the procedure * Active smokers

Design outcomes

Primary

MeasureTime frameDescription
Foot volume3 months post-operativelyThe volume of the operated foot measured by water displacement (in millilitres).

Secondary

MeasureTime frameDescription
MOxFQ score3 months post-operativelyManchester-Oxford Foot Questionnaire score (0-100, 100 being the most severe)
Foot pain assessed using a dolometer3 months post-operativelyFoot pain measured on a visual analogue scale (0-10, 0 being no pain & 10 being worst pain imaginable).
Return to work3 months post-operativelyTime after surgery the participant returned to work (reported in weeks since surgery)

Countries

United Kingdom

Contacts

Primary ContactAlistair M Ewen, Ph. D.
alistair.ewen@gjnh.scot.nhs.uk0141 951 5946
Backup ContactKathryn Macpherson, B. Sc.
kathryn.macpherson@gjnh.scot.nhs.uk0141 951 5121

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026